CXCR7 : Efficacy of a Novel Agonist and Therapeutic Potential of this Receptor
Vol 1 | June 14, 2025
IN THIS ISSUE:
Topline Report: CXCR7 Agonist Efficacy in a Rheumatoid Arthritis Model
CXCR7 (ACKR3) Biology and Therapeutic Strategies
Antagonism
Agonism
Potential Clinical Development in Rheumatoid Arthritis
Disclaimer
Keep reading with a 7-day free trial
Subscribe to Drug Development Executive to keep reading this post and get 7 days of free access to the full post archives.